Business Wire

NY-EMPIRE-STATE-REALTY

21.11.2023 20:59:26 CET | Business Wire | Press release

Share
Most Wonderful Time of the Year: Empire State Building Announces Fan-Favorite Holiday Programs to Include 20th Anniversary Elf Activations, Classic Holiday Décor, Festive Pop-Ups, Special Lightings and More

The Empire State Building (ESB) today announced the details of its annual holiday festivities. Celebrations through the end of the year will include seasonal holiday décor, visits from Santa Claus, pop ups, and special tower lightings.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231121955174/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Most Wonderful Time of the Year: Empire State Building Announces Fan-Favorite Holiday Programs to Include 20th Anniversary Elf Activations, Classic Holiday Décor, Festive Pop-Ups, Special Lightings and More (Photo: Business Wire)

“The holiday season is upon us, and we are excited to provide our guests with one-of-a-kind, holiday-themed experiences here at the Empire State Building,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “This year’s visitors are in for lots of treats -- from photos with Santa to elaborate holiday decorative displays and dedications to the Empire State Building’s co-star, ‘Elf,’ to celebrate the film’s 20th anniversary.”

Deck the Halls
Ornaments, wreaths, tinsel, and bows with silver and gold accents adorn the entire Observatory Experience with a large, bright menorah in front of the two-story building model. Inspired by Santa’s workshop, guests can take their holiday photos on the Empire State Building’s 80th Floor in a snowy corner display with Christmas trees, wrapped presents, a cozy fireplace backdrop, and Santa’s oversized chair.

The building’s landmark Fifth Avenue Lobby, that can be visited after conclusion of guests’ visits to the Observatory, is adorned with hanging holiday lights, wreaths, and an embellished Christmas tree. The iconic Fifth Avenue windows depict snowy scenes of Buddy the Elf and his friends as he travels from the North Pole to the “World’s Most Famous Building.” From Nov. 27 through Dec. 29, tenants and visitors who pass through the Fifth Avenue Lobby from Monday through Friday will hear festive holiday tunes performed by professional pianists.

Santa Claus is Comin’ to Town
On Dec. 2, 9, 11, 13, 16, 18, 20, and 22, Santa Claus himself will collect wish lists, spread holiday cheer, and pose for photos with Observatory guests in his own decorated corner on the 80th Floor. For more information on times, please visit esbnyc.com.

ESB Celebrates the 20th Anniversary of ‘Elf’
The beloved Christmas comedy features Buddy the Elf, who in the famous 2003 film travels to meet his father at his office in the Empire State Building. To celebrate the Christmas classic and the Empire State Building’s lead role in the film, ‘Elf’ will take over the Observatory with themed décor in the building’s Fifth Avenue windows and on the 86th Floor Observatory.

Fans can purchase a special ticket to view ‘Elf’ at one of four screenings on the Observatory’s 80th Floor on Sunday, Dec. 3, 10, 13 and 17. Tickets will include holiday-themed drinks and snacks, and full access to ESB’s second floor museum and 86th Floor Observatory. Tickets can be purchased here.

Baby It’s Cold Outside!
Nov. 23 through Jan. 7 from 10 a.m. to 8:00 p.m., S’mores N’more will pop up to sell their famed hot chocolate with oversized marshmallows to guests who purchase tickets to the 86th Floor Observation deck. Special flavors will include:

  • “The Buddy” -- inspired by ‘Elf’, a classic hot chocolate with whipped cream, a pop tart marshmallow, M&Ms, chocolate, and a maple syrup drizzle
  • “The King” -- inspired by “Kong” himself, a classic hot chocolate with whipped cream, a banana chocolate chip marshmallow, chocolate and banana poke sticks, and cocoa dust
  • “Christmas in the Clouds,” a peppermint hot chocolate with whipped cream, a peppermint marshmallow, a York peppermint patty, and Christmas sprinkles

The Empire State Building’s world-famous outdoor Observatory is also equipped with heaters on the 86th Floor Observation Deck during the chillier months to provide guests with a comfortable viewing experience.

Holiday Lightings
The Empire State Building’s world-famous tower lights will shine throughout the holiday season with dedicated lightings for Thanksgiving, Chanukah, Christmas, and New Year’s Eve. The Empire State Building will also debut its annual holiday music-to-light show.

The Empire State Building’s world-famous Observatory Experience recently underwent a $165 million reimagination that features an interactive museum with nine galleries, brand-new host uniforms, and iconic Observatories on the 86th and 102nd floors. The Observatory Experience was recently named #1 attraction in the U.S. for the second consecutive year by TripAdvisor travelers. Text CONNECT to 274-16 to receive information about each Empire State Building tower lighting. More information about the Empire State Building can be found online.

About the Empire State Building
The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. The Empire State Building Observatory Experience welcomes millions of visitors each year and was declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 attraction in the US for the second year in a row in Tripadvisor’s 2023 Travelers’ Choice Awards: Best of the Best, and the #1 New York City attraction in Lonely Planet’s Ultimate Travel List.

Since 2011, the building has been fully powered by renewable wind electricity, and its many floors house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, X (formerly Twitter), Instagram, Weibo, YouTube, or TikTok.

Source: Empire State Realty Trust, Inc.
Category: Observatory

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231121955174/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye